← Back to headlines
Wegovy Obesity Drug Remains Unreimbursed in Finland
Finland's price board has rejected a pharmaceutical company's application for basic reimbursement of the obesity drug Wegovy, meaning patients will continue to bear the full cost.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Philippines Forecasts 'Extreme Caution' Heat Indices
just now
Enugu State Launches Specialist Training to Combat Maternal Deaths
just now
Katsina First Lady Launches Initiative to Provide Free Sanitary Pads to Schoolgirls
just now
Nigerian Actress Victoria Inyama Shares Female Circumcision Experience
just now